References
- American Cancer Society Cancer Facts and Figures 2013Atlanta, GAAmerican Cancer Society2013 Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/indexAccessed January 11, 2012
- NCCN Guidelines®: Kidney Cancer [webpage on the Internet]National Comprehensive Cancer Network2012 Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed November 3, 2011
- HowladerNNooneAMKrapchoMSEER Cancer Statistics Review 1975–2008 [webpage on the Internet]Bethesda, MDNational Cancer Institute [updated 2011, based on November 2010 SEER data submission]. Available from: http://seer.cancer.gov/csr/1975_2008/Accessed November 3, 2011
- KirchnerHStrumbergDBahlAOvercampFPatient-based strategy systemic treatment of metastatic renal cell carcinomaExpert Rev Anticancer Ther201010458559620397923
- EscudierBAlbigesLSonpavdeGOptimal management of metastatic renal cell carcinoma: current statusDrugs201373542743823572408
- Drugs@FDA [database on the Internet]Silver Spring, MDUS Food Drug Administration Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/Accessed January 11, 2012
- AminAProlonged survival with personalized immunotherapy (AGS-003) in combination with sunitinib in unfavorable risk metastatic RCC (mRCC). Abstract #357Presented at: Genitourinary Cancers SymposiumFebruary 14–16, 2013Orlando, FL
- Guidelines on Renal Cell Carcinoma: Systemic Therapy For Metastatic RCCEuropean Association of Urology2013 Available from: http://www.uroweb.org/guidelines/online-guidelines/Accessed May 14, 2013
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™): Palliative Care. Version 2.2011National Comprehensive Cancer Network2011 Available from: http://www.oralcancerfoundation.org/treatment/pdf/palliative.pdfAccessed August 29, 2012
- AaproMSSupportive care and palliative care: a time for unity in diversityAnn Oncol20122381932193422833274
- ShihYCChienCRXuYPanIWSmithGLBuchholzTAEconomic burden of renal cell carcinoma: part I – an updated reviewPharmacoeconomics201129431532921395351
- YabroffKRLamontEBMariottoACost of care for elderly cancer patients in the United StatesJ Natl Cancer Inst2008100963064118445825
- LangKDanchenkoNGondekKSchwartzBThompsonDThe burden of illness associated with renal cell carcinoma in the United StatesUrol Oncol200725536837517826652
- HollenbeakCSNikkelLESchaeferEWAlemaoEGhahramaniNRamanJDDeterminants of medicare all-cause costs among elderly patients with renal cell carcinomaJ Manag Care Pharm201117861062021942302
- Social Security Administration’s Death Master File (DMF) [webpage on the Internet]US Department of Commerce Available from: http://www.ntis.gov/products/ssa-dmf.aspxAccessed September 1, 2011
- Health Insurance Portability and Accountability Act of 1996 Public Law 104-191 104th Congress2009 Available from: http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdfAccessed October 24, 2011
- KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853457481
- PurmonenTNuttunenPVuorinenRPyrhönenSKatajaVKellokumpu-LehtinenPCurrent and predicted cost of metastatic renal cell carcinoma in FinlandActa Oncologica20104983784320331406
- RemákECharbonneauCNégrierSKimSTMotzerRJEconomic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinomaJ Clin Oncol200826243995400018711190
- Cancer and Medicare: A ChartbookAmerican Cancer Society; Cancer Action Network2009 Available from: http://www.allhealth.org/briefingmaterials/CancerandMedicareChartbookFinalfulldocumentMarch11-1412.pdfAccessed September 4, 2012